Dr. Steven Guggino, MD
Claim this profileLakeland Regional Medical Center
Studies COVID-19
Studies Coronavirus
1 reported clinical trial
5 drugs studied
Affiliated Hospitals
More about Steven Guggino, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Steven Guggino, MD has experience with
- Fluticasone
- Fluvoxamine
- Ivermectin
- Montelukast
- Placebo
Breakdown of trials Steven Guggino, MD has run
Coronavirus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven Guggino, MD specialize in?
Steven Guggino, MD focuses on COVID-19 and Coronavirus. In particular, much of their work with COVID-19 has involved SARS-CoV-2 patients, or patients who are undergoing treatment.
Is Steven Guggino, MD currently recruiting for clinical trials?
No, Steven Guggino, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Steven Guggino, MD has studied deeply?
Yes, Steven Guggino, MD has studied treatments such as Fluticasone, Fluvoxamine, Ivermectin.
What is the best way to schedule an appointment with Steven Guggino, MD?
Apply for one of the trials that Steven Guggino, MD is conducting.
What is the office address of Steven Guggino, MD?
The office of Steven Guggino, MD is located at: Lakeland Regional Medical Center, Lakeland, Florida 33805 United States. This is the address for their practice at the Lakeland Regional Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.